Baylor College of Medicine
Children’s Foundation - Uganda

D3 (Penta 21)

A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression in children with HIV infection aged 2 to <15 years old